Physician profile
John E West
NPI 1437257748
$61,901.73
in general payments reported to CMS, 2019-2025
17 companies · $194 in 2025
The $194 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $50K · 2020: $7,793 · 2021: $3,185 · 2022: $273 · 2023: $161 · 2024: $152 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $32,820.85 | 2019-2022 | |
| Amgen INC. | $28,265.79 | 2019-2025 | Repatha, Repatha |
| Kowa Pharmaceuticals America, INC. | $144.47 | 2019-2023 | Livalo |
| Esperion Therapeutics, INC. | $140.59 | 2021-2025 | Nexletol |
| Novo Nordisk INC | $107.19 | 2019-2020 | |
| Exact Sciences Corporation | $75.70 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $68.23 | 2019-2025 | Shingrix, Arexvy |
| Novartis Pharmaceuticals Corporation | $57.03 | 2019-2024 | |
| Astrazeneca Pharmaceuticals Lp | $42.76 | 2020-2021 | |
| Dexcom, INC. | $41.65 | 2025 | Dexcom G6 Transmitter |
| Horizon Therapeutics Plc | $33.07 | 2023 | Krystexxa |
| Lilly USA, LLC | $25.94 | 2019-2022 | |
| Paratek Pharmaceuticals, INC. | $21.94 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $18.24 | 2019 | |
| Redhill Biopharma INC. | $13.31 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $12.86 | 2019 | |
| Abbvie INC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.